Avita Medical (AVMXY) 1.4600 $AVMXY
Avita Medical Announces Rights Issue Raises $9 Million
Marketwire Canada - Sun Jul 10, 10:08PM CDT
NORTHRIDGE, CA and CAMBRIDGE, UNITED KINGDOM and PERTH, AUSTRALIA--(Marketwired - Jul 10, 2016) - Avita Medical Ltd (ASX: AVH), (OTCQX: AVMXY) today announced it has raised $9 million in a partially underwritten Rights Issue to support the Company's strategy to launch in the US and push forward with product commercialization.
AVH: 6.13 (-0.12)
Avita Medical to Present at Global Chinese Financial Forum
Marketwired - Wed Jun 22, 1:15PM CDT
NORTHRIDGE, CA and PERTH, AUSTRALIA and CAMBRIDGE, UNITED KINGDOM--(Marketwired - Jun 22, 2016) - Avita Medical Ltd (ASX: AVH), (OTCQX: AVMXY), a regenerative medicine company specializing in new treatments for wounds and skin defects, today announced that it will present on its commercial strategy in China at the Global Chinese Financial Forum 23 June 2016 in Shanghai.
AVH: 6.13 (-0.12)
Avita Medical Signs Deal for Distribution in Malaysia
Marketwire Canada - Tue Jun 07, 5:00AM CDT
NORTHRIDGE, CA and PERTH, AUSTRALIA and CAMBRIDGE, UNITED KINGDOM--(Marketwired - Jun 7, 2016) - Avita Medical Limited (ASX: AVH) (OTCQX: AVMXY) has furthered its expansion into the Asian market with the appointment of a specialized wound care distributor for its products in Malaysia.
AVH: 6.13 (-0.12)
Clinical Study in UK to Evaluate ReGenerCell(TM) for Diabetic Foot Ulcer Treatment
Marketwired - Mon May 30, 9:11PM CDT
NORTHRIDGE, CA and PERTH, AUSTRALIA and CAMBRIDGE, UNITED KINGDOM--(Marketwired - May 30, 2016) - Avita Medical Ltd. (ASX: AVH) (OTCQX: AVMXY)
AVH: 6.13 (-0.12)
Avita's Novel ReNovaCell(TM) Technology Offers Key Advantages in Skin Repigmentation of Burn Scars, When Combined With Medical Needling
Marketwired - Mon May 09, 5:00AM CDT
Data Published in Peer-Reviewed Journal Burns
AVH: 6.13 (-0.12)
Research Confirms That ReCell(R) Reduces Long-Term Scarring and Itching Outcomes in Pediatric Burns Treatment
Marketwire Canada - Thu May 05, 7:37PM CDT
UK Study Results Presented at American Burn Association (ABA) Annual Meeting
AVH: 6.13 (-0.12)
Avita Medical's ReCell Technology Demonstrated at Vitiligo Conferences in China
Marketwired - Mon May 02, 9:41PM CDT
Avita Medical Limited (ASX: AVH) (OTCQX: AVMXY)
AVH: 6.13 (-0.12)
Regenerative Medicine Approach Delivers Healing and Cost Savings for Chronic Wounds
Marketwired - Sun May 01, 9:57PM CDT
Avita Medical (ASX: AVH) (OTCQX: AVMXY)
AVH: 6.13 (-0.12)
Avita Medical Announces Financial Results for Third Quarter Fiscal 2016
Marketwired - Fri Apr 29, 1:44AM CDT
Avita Medical Ltd. (ASX: AVH) (OTCQX: AVMXY), a regenerative medicine company specializing in the treatment of wounds and skin defects, today announced its financial results for the third quarter of fiscal 2016 which concluded on March 31, 2016.
AVH: 6.13 (-0.12)
Avita Medical -- Shareholder Letter
Marketwired - Fri Apr 29, 12:50AM CDT
Avita Medical (OTCBB: AVMXY) (ASX: AVH)
AVH: 6.13 (-0.12)
Avita Medical Announces Rights Issue Raises $9 Million
Marketwire Canada - Sun Jul 10, 10:08PM CDT
NORTHRIDGE, CA and CAMBRIDGE, UNITED KINGDOM and PERTH, AUSTRALIA--(Marketwired - Jul 10, 2016) - Avita Medical Ltd (ASX: AVH), (OTCQX: AVMXY) today announced it has raised $9 million in a partially underwritten Rights Issue to support the Company's strategy to launch in the US and push forward with product commercialization.
AVH: 6.13 (-0.12)
Avita Medical to Present at Global Chinese Financial Forum
Marketwired - Wed Jun 22, 1:15PM CDT
NORTHRIDGE, CA and PERTH, AUSTRALIA and CAMBRIDGE, UNITED KINGDOM--(Marketwired - Jun 22, 2016) - Avita Medical Ltd (ASX: AVH), (OTCQX: AVMXY), a regenerative medicine company specializing in new treatments for wounds and skin defects, today announced that it will present on its commercial strategy in China at the Global Chinese Financial Forum 23 June 2016 in Shanghai.
AVH: 6.13 (-0.12)
Avita Medical Signs Deal for Distribution in Malaysia
Marketwire Canada - Tue Jun 07, 5:00AM CDT
NORTHRIDGE, CA and PERTH, AUSTRALIA and CAMBRIDGE, UNITED KINGDOM--(Marketwired - Jun 7, 2016) - Avita Medical Limited (ASX: AVH) (OTCQX: AVMXY) has furthered its expansion into the Asian market with the appointment of a specialized wound care distributor for its products in Malaysia.
AVH: 6.13 (-0.12)
Clinical Study in UK to Evaluate ReGenerCell(TM) for Diabetic Foot Ulcer Treatment
Marketwired - Mon May 30, 9:11PM CDT
NORTHRIDGE, CA and PERTH, AUSTRALIA and CAMBRIDGE, UNITED KINGDOM--(Marketwired - May 30, 2016) - Avita Medical Ltd. (ASX: AVH) (OTCQX: AVMXY)
AVH: 6.13 (-0.12)
Avita's Novel ReNovaCell(TM) Technology Offers Key Advantages in Skin Repigmentation of Burn Scars, When Combined With Medical Needling
Marketwired - Mon May 09, 5:00AM CDT
Data Published in Peer-Reviewed Journal Burns
AVH: 6.13 (-0.12)
Research Confirms That ReCell(R) Reduces Long-Term Scarring and Itching Outcomes in Pediatric Burns Treatment
Marketwire Canada - Thu May 05, 7:37PM CDT
UK Study Results Presented at American Burn Association (ABA) Annual Meeting
AVH: 6.13 (-0.12)
Avita Medical's ReCell Technology Demonstrated at Vitiligo Conferences in China
Marketwired - Mon May 02, 9:41PM CDT
Avita Medical Limited (ASX: AVH) (OTCQX: AVMXY)
AVH: 6.13 (-0.12)
Regenerative Medicine Approach Delivers Healing and Cost Savings for Chronic Wounds
Marketwired - Sun May 01, 9:57PM CDT
Avita Medical (ASX: AVH) (OTCQX: AVMXY)
AVH: 6.13 (-0.12)
Avita Medical Announces Financial Results for Third Quarter Fiscal 2016
Marketwired - Fri Apr 29, 1:44AM CDT
Avita Medical Ltd. (ASX: AVH) (OTCQX: AVMXY), a regenerative medicine company specializing in the treatment of wounds and skin defects, today announced its financial results for the third quarter of fiscal 2016 which concluded on March 31, 2016.
AVH: 6.13 (-0.12)
Avita Medical -- Shareholder Letter
Marketwired - Fri Apr 29, 12:50AM CDT
Avita Medical (OTCBB: AVMXY) (ASX: AVH)
AVH: 6.13 (-0.12)
